Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjuvants.

R Edelman1, C O Tacket

  • 1Department of Medicine, University of Maryland School of Medicine, Baltimore 21201.

International Reviews of Immunology
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Current HIV vaccine research often overlooks adjuvant effectiveness. Future studies must rigorously compare adjuvants and optimize vaccine formulations for enhanced potency and safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Twofold improved tumor-to-brain contrast using a novel T1 relaxation-enhanced steady-state (T<sub>1</sub>RESS) MRI technique.

Science advances·2020
Same author

Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.

The Journal of hospital infection·2016
Same author

Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.

Science (New York, N.Y.)·2011
Same author

Plant-based oral vaccines: results of human trials.

Current topics in microbiology and immunology·2009
Same author

Benign cardiac tumours: cardiac CT and MRI imaging appearances.

Journal of medical imaging and radiation oncology·2009
Same author

Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans.

Mucosal immunology·2008
Same journal

Leptin in metabolic-immune crosstalk: Mechanisms of T cell regulation and implications for autoimmune disease therapy.

International reviews of immunology·2026
Same journal

Metabolic alterations in the tumor microenvironment influence the anti-tumor immune function of CD8<sup>+</sup> T cells via epigenetic modifications.

International reviews of immunology·2026
Same journal

Macrophage markers and gene signature profiling reveals mesenchymal stem cells mediated immune modulation in Plasmodium berghei ANKA infection.

International reviews of immunology·2026
Same journal

Natural antigen landscape shaping intestinal Treg cells: Self, diet, and microbiota.

International reviews of immunology·2026
Same journal

Upregulation of ADAM10 reinforces CD8<sup>+</sup> T cells toward exhaustion in the TME.

International reviews of immunology·2026
Same journal

PTX3 promotes macrophage efferocytosis and inflammation resolution in granulomatous mastitis.

International reviews of immunology·2026
See all related articles

Area of Science:

  • Immunology
  • Vaccinology

Background:

  • Adjuvants are critical for vaccine efficacy but their role in HIV vaccine development is understudied.
  • Existing HIV vaccine studies rarely compare different adjuvants or their specific effects.

Purpose of the Study:

  • To highlight the need for rigorous evaluation of adjuvants in HIV vaccine development.
  • To propose essential design considerations for future HIV vaccine studies focusing on adjuvant optimization.

Main Methods:

  • Review of existing HIV vaccine study designs regarding adjuvant assessment.
  • Identification of key variables influencing vaccine response and adjuvant efficacy.

Main Results:

  • Most HIV vaccine studies lack designs to measure adjuvant effects or compare adjuvants.

Related Experiment Videos

  • Only one study compared HIV antigen alone versus with different adjuvants.

    • Conclusions:

    • Future HIV/SIV vaccine studies require designs that systematically evaluate adjuvant potency and safety.
    • Optimizing vaccine formulation, considering route, schedule, subject factors, antigen characteristics, and immunological endpoints, is crucial for effective HIV vaccines.